HI Cho, G Niu, N Bradley, E Celis. (2008) " Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors. " Cancer Immunol Immunother 57. 1695-703 PMID: 18253731 DOI: 10.1007/s00262-008-0465-x | Abstract and Keywords

S Sas, T Chan, A Sami, A El-Gayed, J Xiang. (2008) " Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice. " Cancer Gene Ther 15. 655-66 PMID: 18421311 DOI: 10.1038/cgt.2008.18 | Abstract and Keywords

DA Sewell, ZK Pan, Y Paterson. (2008) " Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors. " Vaccine 26. 5315-20 PMID: 18680778 DOI: 10.1016/j.vaccine.2008.07.036 | Abstract and Keywords

A Wallecha, PC Maciag, S Rivera, Y Paterson, V Shahabi. (2009) " Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy. " Clin Vaccine Immunol 16. 96-103 PMID: 19020110 DOI: 10.1128/CVI.00274-08 | Abstract and Keywords

D Assudani, HI Cho, N DeVito, N Bradley, E Celis. (2008) " In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. " Cancer Res 68. 9892-9 PMID: 19047170 DOI: 10.1158/0008-5472.CAN-08-3134 | Abstract and Keywords

S Kim, G Buchlis, ZG Fridlender, J Sun, V Kapoor, G Cheng, A Haas, HK Cheung, X Zhang, M Corbley, LR Kaiser, L Ling, SM Albelda. (2008) " Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy. " Cancer Res 68. 10247-56 PMID: 19074893 DOI: 10.1158/0008-5472.CAN-08-1494 | Abstract and Keywords

M Fujita, X Zhu, R Ueda, K Sasaki, G Kohanbash, ER Kastenhuber, HA McDonald, GA Gibson, SC Watkins, R Muthuswamy, P Kalinski, H Okada. (2009) " Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10. " Cancer Res 69. 1587-95 PMID: 19190335 DOI: 10.1158/0008-5472.CAN-08-2915 | Abstract and Keywords

MM Aloysius, AJ Mc Kechnie, RA Robins, C Verma, JM Eremin, F Farzaneh, NA Habib, J Bhalla, NR Hardwick, S Satthaporn, T Sreenivasan, M El-Sheemy, O Eremin. (2009) " Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. " J Transl Med 7. 18 PMID: 19298672 DOI: 10.1186/1479-5876-7-18 | Abstract and Keywords

JW Hodge, J Higgins, J Schlom. (2009) " Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen. " Vaccine 27. 4475-82 PMID: 19450631 DOI: 10.1016/j.vaccine.2009.05.017 | Abstract and Keywords

V Cereda, DJ Poole, C Palena, S Das, TK Bera, C Remondo, JL Gulley, PM Arlen, J Yokokawa, I Pastan, J Schlom, KY Tsang. (2010) " New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. " Cancer Immunol Immunother 59. 63-71 PMID: 19495750 DOI: 10.1007/s00262-009-0723-6 | Abstract and Keywords